Onconic Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,054,864	176,537	-	-	-
Enterprise Value	1,001,450	152,373	-	-	-
Last Close Price	23500.00	4085.00	-	-	-
PS Ratio	22.61	11.90	-	-	-
PB Ratio	15.31	3.15	-	-	-
P/TBV Ratio	15.31	3.15	-	-	-
EV/Sales Ratio	21.47	10.27	-	-	-
Debt / Equity Ratio	0.00	0.01	-0.06	0.00	-0.02
Debt / EBITDA Ratio	0.01	-	0.13	-	-
Debt / FCF Ratio	0.02	-	0.12	-	-
Net Debt / Equity Ratio	-0.77	-0.76	5.05	1.24	2.34
Net Debt / EBITDA Ratio	-4.13	9.82	-11.05	1.85	2.25
Net Debt / FCF Ratio	-7.54	5.35	-9.97	1.56	2.11
Asset Turnover	0.87	0.30	0.62	0.00	-
Quick Ratio	12.64	10.61	0.71	1.06	36.08
Current Ratio	13.21	10.94	0.71	1.06	36.10
Return on Equity (ROE)	33.75%	-32.29%	-	-	-
Return on Assets (ROA)	14.36%	-6.09%	4.07%	-36.85%	-
Return on Capital Employed (ROCE)	18.00%	-8.50%	-39.40%	-343.70%	-44.10%
Earnings Yield	1.59%	-4.58%	-	-	-
FCF Yield	0.67%	-4.52%	-	-	-
Buyback Yield / Dilution	-	-41.46%	0.00%	-0.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.